Robuta

https://www.rcsb.org/structure/5HN9 RCSB PDB - 5HN9: Crystal structure of Plasmodium vivax geranylgeranylpyrophosphate synthase... Crystal structure of Plasmodium vivax geranylgeranylpyrophosphate synthase complexed with BPH-1186 rcsb pdbcrystal structureplasmodium vivaxsynthase https://www.ncbi.nlm.nih.gov/protein/156093097?report=GenPept variable surface protein Vir12-related [Plasmodium vivax] - Protein - NCBI surface proteinplasmodium vivaxvariablerelatedncbi https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2017.01275/full Frontiers | Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite... Plasmodium vivax is the most common species that cause malaria outside of the African continent. The development of an efficacious vaccine would contribute g... the threeplasmodium vivaxfrontiersvaccinecontaining https://www.rcsb.org/structure/5GVM RCSB PDB - 5GVM: Plasmodium vivax SHMT bound with PLP-glycine and GS557 Plasmodium vivax SHMT bound with PLP-glycine and GS557 rcsb pdbplasmodium vivax https://elifesciences.org/articles/04692 Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission | eLife Mathematical models of the build-up and depletion of the hypnozoite reservoir in the liver can inform the design of treatment strategies for preventing... plasmodium vivaxmodellingcontributionhypnozoite https://pmc.ncbi.nlm.nih.gov/articles/PMC5198890/ Diagnosis and Treatment of Plasmodium vivax Malaria - PMC The diagnosis and treatment of Plasmodium vivax malaria differs from that of Plasmodium falciparum malaria in fundamentally important ways. This article... diagnosis and treatmentplasmodium vivaxmalariapmc https://www.cochrane.org/ru/evidence/CD012656_primaquine-cure-people-plasmodium-vivax-malaria-comparing-dosing-schedules Primaquine to cure people with Plasmodium vivax malaria: comparing dosing schedules | Cochrane plasmodium vivax https://www.cochrane.org/evidence/CD004389_primaquine-preventing-relapses-people-plasmodium-vivax-malaria Primaquine for preventing relapses in people with Plasmodium vivax malaria | Cochrane in peopleplasmodium vivaxprimaquinepreventingrelapses https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2017.01148/full Frontiers | Insights into the Cytoadherence Phenomenon of Plasmodium vivax: The Putative Role of... Plasmodium vivax is the most geographically widespread and the dominant human malaria parasite in most countries outside of sub-Saharan Africa and, although ... into theplasmodium vivaxfrontiersinsights https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2021.789417/full Frontiers | Gene Polymorphisms Among Plasmodium vivax Geographical Isolates and the Potential as... The unique biological features of Plasmodium vivax not only make it difficult to control but also to eventually eliminate. For the transmission of the malar... plasmodium vivax https://www.ncbi.nlm.nih.gov/Structure/pdb/4UFW 4UFW: Plasmodium vivax N-myristoyltransferase in complex with a pyridyl inhibitor (compound 22) GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE2-oxopentadecyl-CoA4-chloranyl-N-[2-(3-methoxyphenyl)ethanimidoyl]-2-piperidin-4-yloxy-benzamideCHLORIDE IONDIMETHYL... https://www.rcsb.org/structure/4PFN RCSB PDB - 4PFN: Crystal structure of Plasmodium vivax SHMT with L-serine Schiff base Crystal structure of Plasmodium vivax SHMT with L-serine Schiff base https://pmc.ncbi.nlm.nih.gov/articles/PMC12606953/ Effectiveness of tafenoquine and primaquine for radical cure of Plasmodium vivax: a meeting report... Plasmodium vivax remains the predominant cause of malaria in Pakistan, accounting for approximately 85% of confirmed cases. The recurrent nature of P. vivax,... https://www.frontiersin.org/journals/tropical-diseases/articles/10.3389/fitd.2022.845451/full Frontiers | Influence of CYP2D6, CYP3A4 and CYP2C19 Genotypes on Recurrence of Plasmodium vivax BACKGROUND: The influence of the CYPs in the success of antimalarial therapy remains uncertain. In this study, the association of CYP2D6, CYP2C19 and CYP3A4 ... https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2021.758061/full Frontiers | Genetic Diversity and Natural Selection of Plasmodium vivax Duffy Binding Protein-II... Malaria incidence have declined dramatically over the past decade and, China had been certified malaria-free for indigenous cases within its borders in 2021.... https://www.pasteur.fr/en/home/research-journal/news/malaria-efficacy-new-treatment-plasmodium-vivax?language=fr Malaria: Efficacy of a new treatment for Plasmodium vivax Oct 25, 2022 - Malaria: Efficacy of a new treatment for Plasmodium vivax a newtreatment formalariaefficacyplasmodium https://www.cochrane.org/evidence/CD013218_rapid-tests-diagnosing-malaria-caused-plasmodium-vivax-people-living-areas-where-malaria-very-common Rapid tests for diagnosing malaria caused by Plasmodium vivax in people living in areas where... https://elifesciences.org/articles/72908v1/figures Figures and data in Structural basis of Plasmodium vivax inhibition by antibodies binding to the... https://www.rcsb.org/structure/6D04 RCSB PDB - 6D04: Cryo-EM structure of a Plasmodium vivax invasion complex essential for entry into... Cryo-EM structure of a Plasmodium vivax invasion complex essential for entry into human reticulocytes; two molecules of parasite ligand, subclass 1. https://elifesciences.org/articles/04692v1/peer-reviews Peer review in Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax... peer review https://www.rcsb.org/structure/2BL9 RCSB PDB - 2BL9: X-ray crystal structure of Plasmodium vivax dihydrofolate reductase in complex... X-ray crystal structure of Plasmodium vivax dihydrofolate reductase in complex with pyrimethamine and its derivative x ray crystal structure https://www.cochrane.org/ru/evidence/CD008492_artemisinin-based-combination-therapy-act-treating-non-severe-malaria-due-plasmodium-vivax Artemisinin-based combination therapy (ACT) for treating non-severe malaria due to Plasmodium vivax...